Related Articles
Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets
Non-anti-coagulant heparins: A promising approach for prevention of tumor metastasis (Review)
Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model
The HIP gene encoding a heparin/heparan sulfate interacting protein is mutated in metastatic human colorectal cancer
Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis